517 results on '"Di Paolo, Antonello"'
Search Results
2. Effect of early post-hematopoietic stem cell transplant tacrolimus concentration on transplant outcomes in pediatric recipients: One facility’s ten-year experience of immunosuppression with tacrolimus
3. Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
4. Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients
5. Contributors
6. Predictive “omic” biomarkers of drug response: Colorectal cancer as a model
7. Cytotoxic Drugs
8. A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference mass spectrometry
9. A New Algorithm Integrating Molecular Response, Toxicity, and Plasma Level Measures for Ponatinib Dose Choice in Patients Affected by Chronic Myeloid Leukemia.
10. Discovery of a Potent Dual Inhibitor of Aromatase and Aldosterone Synthase
11. Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?
12. Pharmacogenetics and Personalized Medicine
13. Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis
14. Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study
15. A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center
16. The Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: An Overview
17. Rebuttal letter: Different underlying mechanism might explain the absence of a significant difference in AUC of linezolid for different ABCB1 genotypes
18. Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges
19. Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration–Time Curve of Linezolid for Different ABCB1 Genotypes
20. Genome Wide Association Studies (GWAS)
21. Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia
22. C11 Cytotoxic drugs
23. Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part II
24. Pharmacogenetics of Angiogenesis
25. A Common mdr1 Gene Polymorphism is Associated With Changes in Linezolid Clearance
26. Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
27. Different Recommendations for Daptomycin Dosing Over Time in Patients With Severe Infections
28. Pharmacogenetics of Antiangiogenic Therapy
29. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients
30. First Case of Trichoderma longibrachiatum CIED (Cardiac Implantable Electronic Device)-Associated Endocarditis in a Non-immunocompromised Host: Biofilm Removal and Diagnostic Problems in the Light of the Current Literature
31. Cytotoxic drugs
32. Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review—Part I
33. Effectiveness of a Multifaced Antibiotic Stewardship Program: A Pre-Post Study in Seven Italian ICUs
34. Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update
35. Population pharmacokinetics of daptomycin in patients affected by severe Gram-positive infections
36. Pharmacokinetic drug-drug interaction and their implication in clinical management
37. Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal
38. Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
39. Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer
40. A new validated HPLC-UV method for therapeutic monitoring of daptomycin in comparison with reference LC-MS/MS
41. Determination of mitotane and metabolite by a simple HPLC-UV method and application in plasma samples
42. Chapter 10 - Predictive “omic” biomarkers of drug response: Colorectal cancer as a model
43. A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma
44. Myeloid neoplasms and autoimmune diseases: markers of association
45. Interactions between Food and Drugs, and Nutritional Status in Renal Patients: A Narrative Review
46. EGFR ligands as pharmacodynamic biomarkers in metastatic colorectal cancer patients treated with cetuximab and irinotecan
47. The pharmacological bases of the antiangiogenic activity of paclitaxel
48. Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid
49. Micafungin for Candida Albicans Pacemaker-Associated Endocarditis: A Case Report and Review of the Literature
50. Evaluation of Pharmacokinetics and Pharmacodynamics of Deferasirox in Pediatric Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.